• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

7 Recommendations for Preparing Hospitals for Stages 2 and 3 of Meaningful Use

by Fred Pennic 02/14/2011 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Even though the final requirements for stage 2 and 3 of meaningful use are yet to be released, the preliminary recommendations made by the Health Information Technology Policy Committee’s meaningful use workgroup give a strong hint to what those later stages may require, according to a white paper released by CSC. 

The meaningful use workgroup’s preliminary recommendations include an increased scope or threshold for most stage 1 “core set” measures. For example, one stage 1 core set measure requires more than 30 percent of unique patients with a medication in their medication list to have at least one medication order entered using CPOE. The meaningful use workgroup’s recommendations propose that CPOE be used for at least one medication and one lab or radiology order for 60 percent of patients in stage 2.

Under the preliminary recommendations, most stage 1 “menu set” items would be moved to the “core set,” meaning healthcare providers can no longer defer them. 

In addition to building off of current stage 1 requirements, the preliminary recommendations also propose six entirely new stage 2 measures for eligible hospitals and four entirely new stage 2 measures for eligible professionals. To see the meaningful use workgroup’s full list of recommendations, summarized by CSC, clickhere.

To help healthcare providers reach their goals for meaningful use, CSC has published seven recommendations:

1. “Re-evaluate — and if necessary update — your plan for Stage 1.” In order to build upon successful achievement of stage 1, it will become more and more important for healthcare providers to re-think their strategies for preparation in later stages of meaningful use. 

2. “Do not ignore stage 1 menu set items you have chosen to defer.” CMS has hinted that all menu set items will eventually be required, most likely in stage 2 of meaningful use. Ignoring the menu items you chose to defer in stage 1 will make it more difficult to tackle those menu set items later.

3. “Implement CPOE the right way from the start.” Even though CPOE under stage 1 is limited to medication orders, preparing to implement CPOE for all types of orders from the beginning will better serve providers’ efforts to achieve meaningful use in the long run.

4. “Ensure you have a plan for a robust patient portal.” Involving and engaging patients in the management of their own health and health records will continue to be an integral part of meaningful use. Providers should start planning for a robust patient portal now.

5. “Make sure your system is certified against stage 2 in 2013, regardless of when you are planning to meet stage 1.” Since stage 2 will likely require new capabilities like physician documentation and eMAR, healthcare providers should re-evaluate their individual systems to ensure they will be able to be certified against any new certification criteria adopted under stage 2.

6. “Actively participate in a health information exchange.” Being an active participant in health information exchange will eventually become an integral part of meaningful use. Under the preliminary recommendations from the meaningful use workgroup, bidirectional connection to an HIE would satisfy the objective in both stage 2 and 3.

7. “Keep an eye out for more details on stage 2 requirements related to quality reporting and privacy and security.” Since the meaningful use workgroup’s preliminary recommendations do not discuss potential stage 2 requirements for quality reporting and privacy and security, healthcare providers should watch for future recommendations from the HIT Policy Committee’s quality measure workgroup and privacy and security tiger team.

Learn more about CSC.


Source
  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

2026 Predictions & Trends

Healthcare 2026 Forecast: Executives on AI Survival, Financial Reckoning, and the End of Point Solutions

2026 Healthcare Executive Predictions: Why the AI “Pilot Era” Is Officially Over

Most-Read

HHS Launches 'OneHHS' AI Strategy to Integrate AI Across CDC, CMS, and FDA for Efficiency and Public Trust

HHS Launches ‘OneHHS’ AI Strategy to Integrate AI Across CDC, CMS, and FDA for Efficiency and Public Trust

Kristen Hartsell, VP of Clinical Services, RedSail Technologies

The Pharmacy Closures Crisis: How Independent Pharmacies Are Fixing Pharmacy Deserts

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

The VBC Paradox: Why Hospitals Are Doubling Down on Value-Based Care While Revenue at Risk Lags

The VBC Paradox: Why Hospitals Are Doubling Down on Value-Based Care While Revenue at Risk Lags

Tebra Secures $250M to Challenge Legacy EHRs with AI-Powered Automation

Tebra Secures $250M to Challenge Legacy EHRs with AI-Powered Automation

AstraZeneca Selects Salesforce Agentforce Life Sciences to Deploy AI-Powered Global Customer Engagement

AstraZeneca Selects Salesforce Agentforce Life Sciences to Deploy AI-Powered Global Customer Engagement

Aidoc Partners with NVIDIA MONAI to Scale Open-Source Clinical AI

Aidoc Partners with NVIDIA MONAI to Scale Open-Source Clinical AI

RapidAI Secures FDA Clearance for Five New Deep Clinical AI Modules, Expanding Enterprise Imaging Platform

RapidAI and AWS Deepen Partnership to Scale Clinical AI in Healthcare

Greece and Sword Health to Build AI-Powered Healthcare Front Door

Greece and Sword Health to Build AI-Powered Healthcare Front Door

GE HealthCare Acquires Intelerad for $2.3B to Create Cloud-First, AI-Enabled Imaging Ecosystem

GE HealthCare Acquires Intelerad for $2.3B to Create Cloud-First, AI-Enabled Imaging Ecosystem

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |